全文获取类型
收费全文 | 2853篇 |
免费 | 170篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 88篇 |
妇产科学 | 64篇 |
基础医学 | 261篇 |
口腔科学 | 54篇 |
临床医学 | 280篇 |
内科学 | 588篇 |
皮肤病学 | 44篇 |
神经病学 | 130篇 |
特种医学 | 99篇 |
外科学 | 502篇 |
综合类 | 47篇 |
一般理论 | 7篇 |
预防医学 | 302篇 |
眼科学 | 104篇 |
药学 | 289篇 |
中国医学 | 26篇 |
肿瘤学 | 126篇 |
出版年
2024年 | 8篇 |
2023年 | 32篇 |
2022年 | 105篇 |
2021年 | 112篇 |
2020年 | 83篇 |
2019年 | 122篇 |
2018年 | 139篇 |
2017年 | 103篇 |
2016年 | 112篇 |
2015年 | 110篇 |
2014年 | 143篇 |
2013年 | 205篇 |
2012年 | 252篇 |
2011年 | 266篇 |
2010年 | 140篇 |
2009年 | 130篇 |
2008年 | 178篇 |
2007年 | 159篇 |
2006年 | 144篇 |
2005年 | 128篇 |
2004年 | 90篇 |
2003年 | 85篇 |
2002年 | 55篇 |
2001年 | 23篇 |
2000年 | 12篇 |
1999年 | 9篇 |
1998年 | 12篇 |
1997年 | 12篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1994年 | 6篇 |
1993年 | 2篇 |
1992年 | 7篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1987年 | 5篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1975年 | 5篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1968年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有3042条查询结果,搜索用时 0 毫秒
71.
72.
73.
Cationic Albumin‐Conjugated Chelating Agent as a Novel Brain Drug Delivery System in Neurodegeneration 下载免费PDF全文
Golnaz Kamalinia Fariba Khodagholi Fatemeh Shaerzadeh Faranak Tavssolian Farkhondeh Chaharband Fatemeh Atyabi Mohammad Sharifzadeh Mohsen Amini Rassoul Dinarvand 《Chemical biology & drug design》2015,86(5):1203-1214
The critical role of metal ions and in particular iron in oxidative stress and protein aggregation offers chelation therapy as a sensible pharmaceutical strategy in oxidative stress‐induced neuronal damages. In this research, we conjugated an iron‐chelating agent, deferasirox, to cationized human serum albumin molecules in order to develop a novel brain delivery system for the management of neurodegenerative disorders due to the significant role of oxidative stress‐induced neuronal injury in such diseases. Cationized albumin is known to be able to transport to brain tissue via adsorptive‐mediated transcytosis. The developed structures were molecularly characterized, and their conjugation ratio was determined. PC12 cell line was utilized to evaluate the neuroprotective features of these newly developed molecules in the presence of hydrogen peroxide neuronal damage and to identify the mechanisms behind the observed neuronal protection including apoptotic and autophagic pathways. Furthermore, a rat model of Alzheimer's disease was utilized to evaluate the impact of conjugated structures in vivo. Data analysis revealed that the conjugated species were able to hinder apoptotic cell death while enhancing autophagic process. The developed conjugated species were also able to attenuate amyloid beta‐induced learning deficits when administered peripherally. 相似文献
74.
75.
76.
Teimourian S Zomorodian E Badalzadeh M Pouya A Kannengiesser C Mansouri D Cheraghi T Parvaneh N 《British journal of haematology》2008,141(6):848-851
One of the rarest forms of chronic granulomatous disease (CGD) is caused by mutations in CYBA, which encodes the p22-phox subunit of the phagocyte NADPH oxidase, leading to defective intracellular killing. This study investigated eight patients (six males and two females) from seven consanguineous, unrelated families with clinical CGD, positive family history and p22-phox deficiency. Mutation analysis of CYBA showed six different novel mutations: deletion of exons 3, 4 and 5; a missense mutation in exon 6 (c.373G>A); a splice site mutation in intron 5 (c.369+1G>A); a frameshift in exon 6 (c.385delGAGC); a frameshift in exon 3 (c.174delG); and a frameshift in exon 4 (c.223delC). 相似文献
77.
78.
Samaneh Nakhaee Alireza Amirabadizadeh Jeffrey Brent Ebrahim Miri-Moghaddam Mohsen Foadoddini Khadijeh Farrokhfall 《Critical reviews in toxicology》2019,49(8):710-723
AbstractIntroduction: Tramadol is a synthetic opioid which is commonly used around the world to relieve moderate to severe pain. One of the serious possible complications of its use is seizures. The present study aims to investigate and summarize the studies related to tramadol and occurrences of seizures after tramadol use and factors influencing these seizures.Methodology: Our systematic review is compliant with PRISMA guidelines. Two researchers systematically searched PubMed/Medline, Web of Sciences, and Scopus. Cohort, case-control, cross-sectional studies, and clinical trials. The risk of bias was assessed using the Newcastle–Ottawa Scale After article quality assessment, a fixed or random model, as appropriate, was used to pool the results in a meta-analysis. Heterogeneity between the studies was assessed with using I-square and Q-test. Forest plots demonstrating the point and pooled estimates were drawn.Results: A total of 51 articles with total sample size of 101 770 patients were included. The results showed that seizure event rate in the subgroups of tramadol poisoning, therapeutic dosage of tramadol, and tramadol abusers was 38% (95% CI: 27–49%), 3% (95% CI: 2–3%), 37% (95% CI: 12–62%), respectively. Tramadol dose was significantly higher in the patients with seizures than those without (mean differences: 0.82, CI 95%: 0.17–1.46). The odds for occurrence of seizures were significantly associated with male gender (pooled OR: 2.24, CI 95%: 1.80–2.77). Naloxone administration was not associated to the occurrence of seizures (pooled OR: 0.47, 95% CI: 0.15–1.49).Conclusions: Our results demonstrate that the occurrence of seizures in patients exposed to tramadol are dose-dependent and related to male gender, but not related to naloxone administration. Given that, most of the evidence derives from studies utilizing a cross-sectional design, the association of tramadol with seizures should not be considered to be definitively established 相似文献
79.
80.